Description
The main topic of the meeting will be Treatment Individualization and will focus on the different groups of anticancer agents, i.e., drugs interacting with DNA, tyrosine kinases, hormonal receptors, checkpoints, and inhibitors of angiogenesis. The plenary sessions will consist of presentations by invited speakers followed by proffered papers in the same area. There will also be a poster session. This meeting will bring together an international audience with a wide range of medical-scientific backgrounds. Both fundamental and clinical work will be presented, and the congress should provide an opportunity for extensive interactions among international experts in cancer treatment and care.
